
<!doctype html>
<html lang="en" class="no-js">
  <head>
    
      <meta charset="utf-8">
      <meta name="viewport" content="width=device-width,initial-scale=1">
      
        <meta name="description" content="inspired by Cate Blanchett's Notes on a Scandal">
      
      
        <meta name="author" content="YW Chen">
      
      
        <link rel="canonical" href="https://didiowen.github.io/notes-not-scandal/medicine/antibiotics/">
      
      
        <link rel="prev" href="../cns-infection/">
      
      
        <link rel="next" href="../cns-infection/">
      
      
      <link rel="icon" href="../../assets/virus.png">
      <meta name="generator" content="mkdocs-1.6.1, mkdocs-material-9.5.33">
    
    
      
        <title>Antibiotics - Notes Not Scandal</title>
      
    
    
      <link rel="stylesheet" href="../../assets/stylesheets/main.3cba04c6.min.css">
      
        
        <link rel="stylesheet" href="../../assets/stylesheets/palette.06af60db.min.css">
      
      


    
    
      
    
    
      
        
        
        <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
        <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto:300,300i,400,400i,700,700i%7CRoboto+Mono:400,400i,700,700i&display=fallback">
        <style>:root{--md-text-font:"Roboto";--md-code-font:"Roboto Mono"}</style>
      
    
    
      <link rel="stylesheet" href="../../css/timeago.css">
    
      <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.0.0-beta3/css/all.min.css">
    
    <script>__md_scope=new URL("../..",location),__md_hash=e=>[...e].reduce((e,_)=>(e<<5)-e+_.charCodeAt(0),0),__md_get=(e,_=localStorage,t=__md_scope)=>JSON.parse(_.getItem(t.pathname+"."+e)),__md_set=(e,_,t=localStorage,a=__md_scope)=>{try{t.setItem(a.pathname+"."+e,JSON.stringify(_))}catch(e){}}</script>
    
      

    
    
    
  </head>
  
  
    
    
      
    
    
    
    
    <body dir="ltr" data-md-color-scheme="default" data-md-color-primary="green" data-md-color-accent="amber">
  
    
    <input class="md-toggle" data-md-toggle="drawer" type="checkbox" id="__drawer" autocomplete="off">
    <input class="md-toggle" data-md-toggle="search" type="checkbox" id="__search" autocomplete="off">
    <label class="md-overlay" for="__drawer"></label>
    <div data-md-component="skip">
      
        
        <a href="#antibiotics" class="md-skip">
          Skip to content
        </a>
      
    </div>
    <div data-md-component="announce">
      
    </div>
    
    
      

  

<header class="md-header md-header--shadow md-header--lifted" data-md-component="header">
  <nav class="md-header__inner md-grid" aria-label="Header">
    <a href="../.." title="Notes Not Scandal" class="md-header__button md-logo" aria-label="Notes Not Scandal" data-md-component="logo">
      
  <img src="../../assets/virus.png" alt="logo">

    </a>
    <label class="md-header__button md-icon" for="__drawer">
      
      <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M3 6h18v2H3V6m0 5h18v2H3v-2m0 5h18v2H3v-2Z"/></svg>
    </label>
    <div class="md-header__title" data-md-component="header-title">
      <div class="md-header__ellipsis">
        <div class="md-header__topic">
          <span class="md-ellipsis">
            Notes Not Scandal
          </span>
        </div>
        <div class="md-header__topic" data-md-component="header-topic">
          <span class="md-ellipsis">
            
              Antibiotics
            
          </span>
        </div>
      </div>
    </div>
    
      
        <form class="md-header__option" data-md-component="palette">
  
    
    
    
    <input class="md-option" data-md-color-media="(prefers-color-scheme: light)" data-md-color-scheme="default" data-md-color-primary="green" data-md-color-accent="amber"  aria-label="Switch to dark mode"  type="radio" name="__palette" id="__palette_0">
    
      <label class="md-header__button md-icon" title="Switch to dark mode" for="__palette_1" hidden>
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M17 6H7c-3.31 0-6 2.69-6 6s2.69 6 6 6h10c3.31 0 6-2.69 6-6s-2.69-6-6-6zm0 10H7c-2.21 0-4-1.79-4-4s1.79-4 4-4h10c2.21 0 4 1.79 4 4s-1.79 4-4 4zM7 9c-1.66 0-3 1.34-3 3s1.34 3 3 3 3-1.34 3-3-1.34-3-3-3z"/></svg>
      </label>
    
  
    
    
    
    <input class="md-option" data-md-color-media="(prefers-color-scheme: dark)" data-md-color-scheme="slate" data-md-color-primary="light-green" data-md-color-accent="lime"  aria-label="Switch to light mode"  type="radio" name="__palette" id="__palette_1">
    
      <label class="md-header__button md-icon" title="Switch to light mode" for="__palette_0" hidden>
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M17 7H7a5 5 0 0 0-5 5 5 5 0 0 0 5 5h10a5 5 0 0 0 5-5 5 5 0 0 0-5-5m0 8a3 3 0 0 1-3-3 3 3 0 0 1 3-3 3 3 0 0 1 3 3 3 3 0 0 1-3 3Z"/></svg>
      </label>
    
  
</form>
      
    
    
      <script>var media,input,key,value,palette=__md_get("__palette");if(palette&&palette.color){"(prefers-color-scheme)"===palette.color.media&&(media=matchMedia("(prefers-color-scheme: light)"),input=document.querySelector(media.matches?"[data-md-color-media='(prefers-color-scheme: light)']":"[data-md-color-media='(prefers-color-scheme: dark)']"),palette.color.media=input.getAttribute("data-md-color-media"),palette.color.scheme=input.getAttribute("data-md-color-scheme"),palette.color.primary=input.getAttribute("data-md-color-primary"),palette.color.accent=input.getAttribute("data-md-color-accent"));for([key,value]of Object.entries(palette.color))document.body.setAttribute("data-md-color-"+key,value)}</script>
    
    
    
      <label class="md-header__button md-icon" for="__search">
        
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M9.5 3A6.5 6.5 0 0 1 16 9.5c0 1.61-.59 3.09-1.56 4.23l.27.27h.79l5 5-1.5 1.5-5-5v-.79l-.27-.27A6.516 6.516 0 0 1 9.5 16 6.5 6.5 0 0 1 3 9.5 6.5 6.5 0 0 1 9.5 3m0 2C7 5 5 7 5 9.5S7 14 9.5 14 14 12 14 9.5 12 5 9.5 5Z"/></svg>
      </label>
      <div class="md-search" data-md-component="search" role="dialog">
  <label class="md-search__overlay" for="__search"></label>
  <div class="md-search__inner" role="search">
    <form class="md-search__form" name="search">
      <input type="text" class="md-search__input" name="query" aria-label="Search" placeholder="Search" autocapitalize="off" autocorrect="off" autocomplete="off" spellcheck="false" data-md-component="search-query" required>
      <label class="md-search__icon md-icon" for="__search">
        
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M9.5 3A6.5 6.5 0 0 1 16 9.5c0 1.61-.59 3.09-1.56 4.23l.27.27h.79l5 5-1.5 1.5-5-5v-.79l-.27-.27A6.516 6.516 0 0 1 9.5 16 6.5 6.5 0 0 1 3 9.5 6.5 6.5 0 0 1 9.5 3m0 2C7 5 5 7 5 9.5S7 14 9.5 14 14 12 14 9.5 12 5 9.5 5Z"/></svg>
        
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M20 11v2H8l5.5 5.5-1.42 1.42L4.16 12l7.92-7.92L13.5 5.5 8 11h12Z"/></svg>
      </label>
      <nav class="md-search__options" aria-label="Search">
        
        <button type="reset" class="md-search__icon md-icon" title="Clear" aria-label="Clear" tabindex="-1">
          
          <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M19 6.41 17.59 5 12 10.59 6.41 5 5 6.41 10.59 12 5 17.59 6.41 19 12 13.41 17.59 19 19 17.59 13.41 12 19 6.41Z"/></svg>
        </button>
      </nav>
      
    </form>
    <div class="md-search__output">
      <div class="md-search__scrollwrap" tabindex="0" data-md-scrollfix>
        <div class="md-search-result" data-md-component="search-result">
          <div class="md-search-result__meta">
            Initializing search
          </div>
          <ol class="md-search-result__list" role="presentation"></ol>
        </div>
      </div>
    </div>
  </div>
</div>
    
    
  </nav>
  
    
      
<nav class="md-tabs" aria-label="Tabs" data-md-component="tabs">
  <div class="md-grid">
    <ul class="md-tabs__list">
      
        
  
  
    
  
  
    <li class="md-tabs__item md-tabs__item--active">
      <a href="../.." class="md-tabs__link">
        
  
    
  
  Home

      </a>
    </li>
  

      
        
  
  
  
    
    
      <li class="md-tabs__item">
        <a href="../../Slides/" class="md-tabs__link">
          
  
    
  
  Slides

        </a>
      </li>
    
  

      
        
  
  
  
    
    
      <li class="md-tabs__item">
        <a href="../../%E5%B0%88%E5%B8%AB%E8%80%83%E8%A9%A6%E8%A7%A3%E9%A1%8C/" class="md-tabs__link">
          
  
    
  
  專師考試解題

        </a>
      </li>
    
  

      
        
  
  
  
    
    
      <li class="md-tabs__item">
        <a href="../../archive/2025/11/" class="md-tabs__link">
          
  
    
  
  Archive

        </a>
      </li>
    
  

      
        
  
  
  
    
    
      <li class="md-tabs__item">
        <a href="../../category/abx/" class="md-tabs__link">
          
  
    
  
  Categories

        </a>
      </li>
    
  

      
    </ul>
  </div>
</nav>
    
  
</header>
    
    <div class="md-container" data-md-component="container">
      
      
        
      
      <main class="md-main" data-md-component="main">
        <div class="md-main__inner md-grid">
          
            
              
                
              
              <div class="md-sidebar md-sidebar--primary" data-md-component="sidebar" data-md-type="navigation" hidden>
                <div class="md-sidebar__scrollwrap">
                  <div class="md-sidebar__inner">
                    


  


<nav class="md-nav md-nav--primary md-nav--lifted" aria-label="Navigation" data-md-level="0">
  <label class="md-nav__title" for="__drawer">
    <a href="../.." title="Notes Not Scandal" class="md-nav__button md-logo" aria-label="Notes Not Scandal" data-md-component="logo">
      
  <img src="../../assets/virus.png" alt="logo">

    </a>
    Notes Not Scandal
  </label>
  
  <ul class="md-nav__list" data-md-scrollfix>
    
      
      
  
  
    
  
  
  
    <li class="md-nav__item md-nav__item--active">
      <a href="../.." class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Home
  </span>
  

      </a>
    </li>
  

    
      
      
  
  
  
  
    
    
      
        
          
        
      
        
      
    
    
      
      
        
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
        <input class="md-nav__toggle md-toggle " type="checkbox" id="__nav_2" >
        
          
          
          <div class="md-nav__link md-nav__container">
            <a href="../../Slides/" class="md-nav__link ">
              
  
  <span class="md-ellipsis">
    Slides
  </span>
  

            </a>
            
              
              <label class="md-nav__link " for="__nav_2" id="__nav_2_label" tabindex="0">
                <span class="md-nav__icon md-icon"></span>
              </label>
            
          </div>
        
        <nav class="md-nav" data-md-level="1" aria-labelledby="__nav_2_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_2">
            <span class="md-nav__icon md-icon"></span>
            Slides
          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
            
              
                
  
  
  
  
    
    
      
        
      
        
      
        
      
        
      
    
    
      
      
        
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
        <input class="md-nav__toggle md-toggle " type="checkbox" id="__nav_2_2" >
        
          
          <label class="md-nav__link" for="__nav_2_2" id="__nav_2_2_label" tabindex="0">
            
  
  <span class="md-ellipsis">
    Plugin
  </span>
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_2_2_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_2_2">
            <span class="md-nav__icon md-icon"></span>
            Plugin
          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    
    
      
        
          
        
      
    
    
      
      
        
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
        <input class="md-nav__toggle md-toggle " type="checkbox" id="__nav_2_2_1" >
        
          
          
          <div class="md-nav__link md-nav__container">
            <a href="../../Slides/plugin/chalkboard/" class="md-nav__link ">
              
  
  <span class="md-ellipsis">
    Chalkboard
  </span>
  

            </a>
            
          </div>
        
        <nav class="md-nav" data-md-level="3" aria-labelledby="__nav_2_2_1_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_2_2_1">
            <span class="md-nav__icon md-icon"></span>
            Chalkboard
          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
            
          </ul>
        </nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    
    
      
        
          
        
      
    
    
      
      
        
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
        <input class="md-nav__toggle md-toggle " type="checkbox" id="__nav_2_2_2" >
        
          
          
          <div class="md-nav__link md-nav__container">
            <a href="../../Slides/plugin/chart/" class="md-nav__link ">
              
  
  <span class="md-ellipsis">
    Chart
  </span>
  

            </a>
            
          </div>
        
        <nav class="md-nav" data-md-level="3" aria-labelledby="__nav_2_2_2_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_2_2_2">
            <span class="md-nav__icon md-icon"></span>
            Chart
          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
            
          </ul>
        </nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    
    
      
        
          
        
      
    
    
      
      
        
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
        <input class="md-nav__toggle md-toggle " type="checkbox" id="__nav_2_2_3" >
        
          
          
          <div class="md-nav__link md-nav__container">
            <a href="../../Slides/plugin/customcontrols/" class="md-nav__link ">
              
  
  <span class="md-ellipsis">
    Customcontrols
  </span>
  

            </a>
            
          </div>
        
        <nav class="md-nav" data-md-level="3" aria-labelledby="__nav_2_2_3_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_2_2_3">
            <span class="md-nav__icon md-icon"></span>
            Customcontrols
          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
            
          </ul>
        </nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    
    
      
        
          
        
      
        
      
    
    
      
      
        
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
        <input class="md-nav__toggle md-toggle " type="checkbox" id="__nav_2_2_4" >
        
          
          
          <div class="md-nav__link md-nav__container">
            <a href="../../Slides/plugin/menu/" class="md-nav__link ">
              
  
  <span class="md-ellipsis">
    Menu
  </span>
  

            </a>
            
              
              <label class="md-nav__link " for="__nav_2_2_4" id="__nav_2_2_4_label" tabindex="0">
                <span class="md-nav__icon md-icon"></span>
              </label>
            
          </div>
        
        <nav class="md-nav" data-md-level="3" aria-labelledby="__nav_2_2_4_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_2_2_4">
            <span class="md-nav__icon md-icon"></span>
            Menu
          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../Slides/plugin/menu/CONTRIBUTING/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    CONTRIBUTING
  </span>
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

    
      
      
  
  
  
  
    
    
      
        
          
        
      
    
    
      
      
        
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
        <input class="md-nav__toggle md-toggle " type="checkbox" id="__nav_3" >
        
          
          
          <div class="md-nav__link md-nav__container">
            <a href="../../%E5%B0%88%E5%B8%AB%E8%80%83%E8%A9%A6%E8%A7%A3%E9%A1%8C/" class="md-nav__link ">
              
  
  <span class="md-ellipsis">
    專師考試解題
  </span>
  

            </a>
            
          </div>
        
        <nav class="md-nav" data-md-level="1" aria-labelledby="__nav_3_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3">
            <span class="md-nav__icon md-icon"></span>
            專師考試解題
          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
            
          </ul>
        </nav>
      
    </li>
  

    
      
      
  
  
  
  
    
    
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
    
    
      
      
        
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
        <input class="md-nav__toggle md-toggle " type="checkbox" id="__nav_4" >
        
          
          <label class="md-nav__link" for="__nav_4" id="__nav_4_label" tabindex="0">
            
  
  <span class="md-ellipsis">
    Archive
  </span>
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="1" aria-labelledby="__nav_4_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_4">
            <span class="md-nav__icon md-icon"></span>
            Archive
          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../archive/2025/11/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    2025/11
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../archive/2025/03/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    2025/03
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../archive/2025/02/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    2025/02
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../archive/2024/11/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    2024/11
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../archive/2024/10/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    2024/10
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../archive/2024/09/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    2024/09
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../archive/2024/08/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    2024/08
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../archive/2024/07/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    2024/07
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../archive/2024/05/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    2024/05
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../archive/2024/04/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    2024/04
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../archive/2024/03/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    2024/03
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../archive/2024/02/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    2024/02
  </span>
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

    
      
      
  
  
  
  
    
    
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
    
    
      
      
        
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
        <input class="md-nav__toggle md-toggle " type="checkbox" id="__nav_5" >
        
          
          <label class="md-nav__link" for="__nav_5" id="__nav_5_label" tabindex="0">
            
  
  <span class="md-ellipsis">
    Categories
  </span>
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="1" aria-labelledby="__nav_5_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_5">
            <span class="md-nav__icon md-icon"></span>
            Categories
          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../category/abx/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    abx
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../category/hiv/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    hiv
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../category/medicine/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    medicine
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../category/reading/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    reading
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../category/tb/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    tb
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../category/theatre/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    theatre
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../category/trauma/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    trauma
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../category/watching/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    watching
  </span>
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

    
  </ul>
</nav>
                  </div>
                </div>
              </div>
            
            
              
                
              
              <div class="md-sidebar md-sidebar--secondary" data-md-component="sidebar" data-md-type="toc" >
                <div class="md-sidebar__scrollwrap">
                  <div class="md-sidebar__inner">
                    

  

<nav class="md-nav md-nav--secondary" aria-label="Table of contents">
  
  
  
    
  
  
    <label class="md-nav__title" for="__toc">
      <span class="md-nav__icon md-icon"></span>
      Table of contents
    </label>
    <ul class="md-nav__list" data-md-component="toc" data-md-scrollfix>
      
        <li class="md-nav__item">
  <a href="#_1" class="md-nav__link">
    <span class="md-ellipsis">
      作用機制
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#_2" class="md-nav__link">
    <span class="md-ellipsis">
      抗藥性機轉
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#pharmakokinetics" class="md-nav__link">
    <span class="md-ellipsis">
      藥物動力學 (Pharmakokinetics)
    </span>
  </a>
  
    <nav class="md-nav" aria-label="藥物動力學 (Pharmakokinetics)">
      <ul class="md-nav__list">
        
          <li class="md-nav__item">
  <a href="#penetrationtissue-concentration" class="md-nav__link">
    <span class="md-ellipsis">
      Penetration/Tissue concentration
    </span>
  </a>
  
    <nav class="md-nav" aria-label="Penetration/Tissue concentration">
      <ul class="md-nav__list">
        
          <li class="md-nav__item">
  <a href="#bone-penetration-for-selected-antibiotics" class="md-nav__link">
    <span class="md-ellipsis">
      Bone penetration for selected antibiotics
    </span>
  </a>
  
</li>
        
      </ul>
    </nav>
  
</li>
        
      </ul>
    </nav>
  
</li>
      
        <li class="md-nav__item">
  <a href="#pharmakodynamics" class="md-nav__link">
    <span class="md-ellipsis">
      藥效動力學 (Pharmakodynamics)
    </span>
  </a>
  
    <nav class="md-nav" aria-label="藥效動力學 (Pharmakodynamics)">
      <ul class="md-nav__list">
        
          <li class="md-nav__item">
  <a href="#_3" class="md-nav__link">
    <span class="md-ellipsis">
      濃度依賴型抗生素
    </span>
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#_4" class="md-nav__link">
    <span class="md-ellipsis">
      時間依賴型抗生素
    </span>
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#_5" class="md-nav__link">
    <span class="md-ellipsis">
      曲線下面積/最低抑菌濃度相關
    </span>
  </a>
  
</li>
        
      </ul>
    </nav>
  
</li>
      
        <li class="md-nav__item">
  <a href="#_6" class="md-nav__link">
    <span class="md-ellipsis">
      抗菌範圍
    </span>
  </a>
  
    <nav class="md-nav" aria-label="抗菌範圍">
      <ul class="md-nav__list">
        
          <li class="md-nav__item">
  <a href="#anfi-fungals" class="md-nav__link">
    <span class="md-ellipsis">
      Anfi-fungals
    </span>
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#mdro" class="md-nav__link">
    <span class="md-ellipsis">
      MDRO
    </span>
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#_7" class="md-nav__link">
    <span class="md-ellipsis">
      特殊細菌
    </span>
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#drugs-of-choices" class="md-nav__link">
    <span class="md-ellipsis">
      Drugs of choices
    </span>
  </a>
  
</li>
        
      </ul>
    </nav>
  
</li>
      
        <li class="md-nav__item">
  <a href="#_8" class="md-nav__link">
    <span class="md-ellipsis">
      本院有的抗生素
    </span>
  </a>
  
    <nav class="md-nav" aria-label="本院有的抗生素">
      <ul class="md-nav__list">
        
          <li class="md-nav__item">
  <a href="#cephalosporins" class="md-nav__link">
    <span class="md-ellipsis">
      Cephalosporins
    </span>
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#penicillins" class="md-nav__link">
    <span class="md-ellipsis">
      Penicillins
    </span>
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#carbapenems" class="md-nav__link">
    <span class="md-ellipsis">
      Carbapenems
    </span>
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#aminoglycosides" class="md-nav__link">
    <span class="md-ellipsis">
      Aminoglycosides
    </span>
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#fluoroquinolones" class="md-nav__link">
    <span class="md-ellipsis">
      Fluoroquinolones
    </span>
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#tetracyclines" class="md-nav__link">
    <span class="md-ellipsis">
      Tetracyclines
    </span>
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#macrolides" class="md-nav__link">
    <span class="md-ellipsis">
      Macrolides
    </span>
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#glycopeptides-lipoglycopeptides-daptomycin-oxazolidinones" class="md-nav__link">
    <span class="md-ellipsis">
      Glycopeptides, lipoglycopeptides, daptomycin, oxazolidinones
    </span>
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#other-anti-bacterials" class="md-nav__link">
    <span class="md-ellipsis">
      Other anti-bacterials
    </span>
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#anti-fungals" class="md-nav__link">
    <span class="md-ellipsis">
      Anti-fungals
    </span>
  </a>
  
</li>
        
      </ul>
    </nav>
  
</li>
      
        <li class="md-nav__item">
  <a href="#_9" class="md-nav__link">
    <span class="md-ellipsis">
      孕婦
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#_10" class="md-nav__link">
    <span class="md-ellipsis">
      常見副作用
    </span>
  </a>
  
    <nav class="md-nav" aria-label="常見副作用">
      <ul class="md-nav__list">
        
          <li class="md-nav__item">
  <a href="#ampicillinsulbactam" class="md-nav__link">
    <span class="md-ellipsis">
      Ampicillin/sulbactam
    </span>
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#piperacillintazobactam" class="md-nav__link">
    <span class="md-ellipsis">
      Piperacillin/tazobactam
    </span>
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#ceftriaxone" class="md-nav__link">
    <span class="md-ellipsis">
      Ceftriaxone
    </span>
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#cefepime" class="md-nav__link">
    <span class="md-ellipsis">
      Cefepime
    </span>
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#carbapenems_1" class="md-nav__link">
    <span class="md-ellipsis">
      Carbapenems
    </span>
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#aminoglycosides-gentamicin" class="md-nav__link">
    <span class="md-ellipsis">
      Aminoglycosides (Gentamicin)
    </span>
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#sulfamethoxazoletrimethoprim-tmp-smx" class="md-nav__link">
    <span class="md-ellipsis">
      Sulfamethoxazole/Trimethoprim (TMP-SMX)
    </span>
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#vancomycin" class="md-nav__link">
    <span class="md-ellipsis">
      Vancomycin
    </span>
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#daptomycin" class="md-nav__link">
    <span class="md-ellipsis">
      Daptomycin
    </span>
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#linezolid" class="md-nav__link">
    <span class="md-ellipsis">
      Linezolid
    </span>
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#clindamycin" class="md-nav__link">
    <span class="md-ellipsis">
      Clindamycin
    </span>
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#tetracyclines-doxycycline-minocycline" class="md-nav__link">
    <span class="md-ellipsis">
      Tetracyclines (如doxycycline, minocycline)
    </span>
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#fluoroquinolones_1" class="md-nav__link">
    <span class="md-ellipsis">
      Fluoroquinolones
    </span>
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#macrolides_1" class="md-nav__link">
    <span class="md-ellipsis">
      Macrolides
    </span>
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#metronidazole" class="md-nav__link">
    <span class="md-ellipsis">
      Metronidazole
    </span>
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#fluconazole" class="md-nav__link">
    <span class="md-ellipsis">
      Fluconazole
    </span>
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#amphotericin-b" class="md-nav__link">
    <span class="md-ellipsis">
      Amphotericin B
    </span>
  </a>
  
</li>
        
      </ul>
    </nav>
  
</li>
      
        <li class="md-nav__item">
  <a href="#_11" class="md-nav__link">
    <span class="md-ellipsis">
      考古題
    </span>
  </a>
  
    <nav class="md-nav" aria-label="考古題">
      <ul class="md-nav__list">
        
          <li class="md-nav__item">
  <a href="#_12" class="md-nav__link">
    <span class="md-ellipsis">
      專師
    </span>
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#_13" class="md-nav__link">
    <span class="md-ellipsis">
      通論
    </span>
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#_14" class="md-nav__link">
    <span class="md-ellipsis">
      外科
    </span>
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#_15" class="md-nav__link">
    <span class="md-ellipsis">
      內科醫師
    </span>
  </a>
  
</li>
        
      </ul>
    </nav>
  
</li>
      
    </ul>
  
</nav>
                  </div>
                </div>
              </div>
            
          
          
  <div class="md-content md-content--post" data-md-component="content">
    <div class="md-sidebar md-sidebar--post" data-md-component="sidebar" data-md-type="navigation">
      <div class="md-sidebar__scrollwrap">
        <div class="md-sidebar__inner md-post">
          <nav class="md-nav md-nav--primary">
            <div class="md-post__back">
              <div class="md-nav__title md-nav__container">
                <a href="../.." class="md-nav__link">
                  <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M20 11v2H8l5.5 5.5-1.42 1.42L4.16 12l7.92-7.92L13.5 5.5 8 11h12Z"/></svg>
                  <span class="md-ellipsis">
                    Back to index
                  </span>
                </a>
              </div>
            </div>
            
            <ul class="md-post__meta md-nav__list">
              <li class="md-nav__item md-nav__item--section">
                <div class="md-post__title">
                  <span class="md-ellipsis">
                    Metadata
                  </span>
                </div>
                <nav class="md-nav">
                  <ul class="md-nav__list">
                    <li class="md-nav__item">
                      <div class="md-nav__link">
                        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M19 19H5V8h14m-3-7v2H8V1H6v2H5c-1.11 0-2 .89-2 2v14a2 2 0 0 0 2 2h14a2 2 0 0 0 2-2V5a2 2 0 0 0-2-2h-1V1m-1 11h-5v5h5v-5Z"/></svg>
                        <time datetime="2024-08-09 15:56:51" class="md-ellipsis">August 9, 2024</time>
                      </div>
                    </li>
                    
                      <li class="md-nav__item">
                        <div class="md-nav__link">
                          <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M15 13h1.5v2.82l2.44 1.41-.75 1.3L15 16.69V13m4-5H5v11h4.67c-.43-.91-.67-1.93-.67-3a7 7 0 0 1 7-7c1.07 0 2.09.24 3 .67V8M5 21a2 2 0 0 1-2-2V5c0-1.11.89-2 2-2h1V1h2v2h8V1h2v2h1a2 2 0 0 1 2 2v6.1c1.24 1.26 2 2.99 2 4.9a7 7 0 0 1-7 7c-1.91 0-3.64-.76-4.9-2H5m11-9.85A4.85 4.85 0 0 0 11.15 16c0 2.68 2.17 4.85 4.85 4.85A4.85 4.85 0 0 0 20.85 16c0-2.68-2.17-4.85-4.85-4.85Z"/></svg>
                          <time datetime="2025-05-22 13:52:09" class="md-ellipsis">May 22, 2025</time>
                        </div>
                      </li>
                    
                    
                      <li class="md-nav__item">
                        <div class="md-nav__link">
                          <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M9 3v15h3V3H9m3 2 4 13 3-1-4-13-3 1M5 5v13h3V5H5M3 19v2h18v-2H3Z"/></svg>
                          <span class="md-ellipsis">
                            in
                            
                              <a href="../../category/medicine/">medicine</a>, 
                              <a href="../../category/abx/">abx</a></span>
                        </div>
                      </li>
                    
                    
                      
                      <li class="md-nav__item">
                        <div class="md-nav__link">
                          <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M12 20a8 8 0 0 0 8-8 8 8 0 0 0-8-8 8 8 0 0 0-8 8 8 8 0 0 0 8 8m0-18a10 10 0 0 1 10 10 10 10 0 0 1-10 10C6.47 22 2 17.5 2 12A10 10 0 0 1 12 2m.5 5v5.25l4.5 2.67-.75 1.23L11 13V7h1.5Z"/></svg>
                          <span class="md-ellipsis">
                            
                              13 min read
                            
                          </span>
                        </div>
                      </li>
                    
                  </ul>
                </nav>
              </li>
            </ul>
          </nav>
          
        </div>
      </div>
    </div>
    <article class="md-content__inner md-typeset">
      
        


<h1 id="antibiotics">Antibiotics<a class="headerlink" href="#antibiotics" title="Permanent link">&para;</a></h1>
<p>up:: 專師考試解題  </p>
<h2 id="_1">作用機制<a class="headerlink" href="#_1" title="Permanent link">&para;</a></h2>
<p><img alt="mechanism" src="../assets/d5cd1072950af118968f9283c66a7d7c_md5.jpeg" />  </p>
<!-- more -->

<table>
<thead>
<tr>
<th>ANTIBACTERIAL AGENT(S)</th>
<th>MAJOR TARGET</th>
<th>MECHANISM(S) OF ACTION</th>
<th>MECHANISM(S) OF RESISTANCE</th>
</tr>
</thead>
<tbody>
<tr>
<td>β-Lactams (penicillins, cephalosporins, monobactams, carbapenems)</td>
<td>Cell-wall synthesis</td>
<td>Bind cell-wall cross-linking enzymes (PBPs, <strong>transpeptidases</strong>)</td>
<td>1. Drug inactivation by β-lactamases<br>    <br>2. Altered PBP targets<br>    <br>3. Reduced diffusion through porin channels<br>    <br>4. Altered iron uptake proteins (cefiderocol)</td>
</tr>
<tr>
<td>Glycopeptides and lipoglycopeptides (vancomycin, teicoplanin, telavancin, dalbavancin, oritavancin)</td>
<td>Cell-wall synthesis</td>
<td>Block cell wall glycosyltransferases by binding D-Ala-D-Ala stem-peptide terminus<br><br>Teicoplanin, telavancin, dalbavancin, and oritavancin: affect membrane function</td>
<td>1. Altered D-Ala-D-Ala target (D-Ala-D-Lac)<br>    <br>2. Increased D-Ala-D-Ala target binding at sites distant from cell wall synthesis enzymes</td>
</tr>
<tr>
<td>Bacitracin</td>
<td>Cell-wall synthesis</td>
<td>Blocks lipid carrier of cell wall precursors</td>
<td>Active drug efflux</td>
</tr>
<tr>
<td>Fosfomycin</td>
<td>Cell-wall synthesis</td>
<td>Blocks linkage of stem peptide to NAG by enoyltransferase</td>
<td>1. Target enzyme overexpression<br>    <br>2. Drug-modifying enzymes</td>
</tr>
<tr>
<td>Aminoglycosides (gentamicin, tobramycin, amikacin, plazomicin)</td>
<td>Protein synthesis</td>
<td>Bind 30S ribosomal subunit<br><br>Block translocation of peptide chain<br><br>Cause misreading of mRNA</td>
<td>1. Drug-modifying enzymes<br>    <br>2. Methylation at ribosome binding site<br>    <br>3. Decreased permeation to target due to active efflux</td>
</tr>
<tr>
<td>Tetracyclines (tetracycline, doxycycline, minocycline)</td>
<td>Protein synthesis</td>
<td>Bind 30S ribosomal subunit<br><br>Inhibit peptide elongation</td>
<td>1. Active drug efflux<br>    <br>2. Ribosomal protection proteins</td>
</tr>
<tr>
<td>Tigecycline, eravacyclin, omadacycline</td>
<td>Protein synthesis</td>
<td>Same as tetracyclines</td>
<td>Active drug efflux (pumps different from those affecting tetracyclines)</td>
</tr>
<tr>
<td>Macrolides (erythromycin, clarithromycin, azithromycin) and the ketolide telithromycin</td>
<td>Protein synthesis</td>
<td>Bind 50S ribosomal subunit<br><br>Block peptide chain exit</td>
<td>1. Methylation at ribosome binding site<br>    <br>2. Active drug efflux</td>
</tr>
<tr>
<td>Lincosamides (clindamycin)</td>
<td>Protein synthesis</td>
<td>Bind 50S ribosomal subunit<br><br>Block peptide bond formation</td>
<td>Methylation at ribosome binding site</td>
</tr>
<tr>
<td>Streptogramins (quinupristin, dalfopristin)</td>
<td>Protein synthesis</td>
<td>Same as macrolides</td>
<td>1. Same as macrolides<br>    <br>2. Drug-modifying enzymes</td>
</tr>
<tr>
<td>Chloramphenicol</td>
<td>Protein synthesis</td>
<td>Binds 50S ribosomal subunit<br><br>Blocks aminoacyl tRNA positioning</td>
<td>Drug-modifying enzymes</td>
</tr>
<tr>
<td>Oxazolidinones (linezolid, tedizolid)</td>
<td>Protein synthesis</td>
<td>Bind 50S ribosomal subunit<br><br>Inhibit initiation of peptide synthesis</td>
<td>1. Altered rRNA binding site<br>    <br>2. Methylation of ribosome binding site</td>
</tr>
<tr>
<td>Pleuromutilins (lefamulin)</td>
<td>Protein synthesis</td>
<td>Bind 50S ribosomal subunit<br><br>Blocks peptidyl transferase center</td>
<td>1. Altered L3 and L4 protein binding site<br>    <br>2. Methylation of ribosome binding site</td>
</tr>
<tr>
<td>Mupirocin</td>
<td>Protein synthesis</td>
<td>Blocks isoleucyl tRNA synthetase</td>
<td>1. Acquired resistant tRNA synthetase (drug bypass)<br>    <br>2. Altered native tRNA synthetase target</td>
</tr>
<tr>
<td>Sulfonamides (sulfadiazine, sulfisoxazole, and sulfamethoxazole)</td>
<td>Folate synthesis</td>
<td>Inhibit dihydropteroate synthetase</td>
<td>Acquired resistant dihydropteroate synthetase (drug bypass)</td>
</tr>
<tr>
<td>Trimethoprim</td>
<td>Folate synthesis</td>
<td>Inhibits dihydrofolate reductase</td>
<td>Acquired resistant dihydrofolate reductase (drug bypass)</td>
</tr>
<tr>
<td>Quinolones (norfloxacin, ciprofloxacin, ofloxacin, levofloxacin, moxifloxacin, gemifloxacin, delafloxacin)</td>
<td>DNA synthesis</td>
<td>Inhibit DNA gyrase and DNA topoisomerase IV<br><br>Enzyme–DNA–drug complex: blocks DNA replication apparatus</td>
<td>1. Altered target(s)<br>    <br>2. Active efflux<br>    <br>3. Protection of target from drug<br>    <br>4. Drug-modifying enzyme (ciprofloxacin)</td>
</tr>
<tr>
<td>Rifamycins (rifampin, rifabutin, rifapentine)</td>
<td>RNA synthesis</td>
<td>Inhibit RNA polymerase</td>
<td>Altered target</td>
</tr>
<tr>
<td>Nitrofurantoin</td>
<td>Nucleic acid synthesis</td>
<td>Reduces reactive drug derivatives that damage DNA</td>
<td>Altered drug-activating enzymes</td>
</tr>
<tr>
<td>Metronidazole</td>
<td>Nucleic acid synthesis</td>
<td>Reduces reactive drug derivatives that damage DNA</td>
<td>1. Altered drug-activating enzyme<br>    <br>2. Acquired detoxifying enzymes<br>    <br>3. Active efflux</td>
</tr>
<tr>
<td>Polymyxins (polymyxin B and polymyxin E [colistin])</td>
<td>Cell membrane</td>
<td>Bind LPS and disrupt both outer and cytoplasmic membranes</td>
<td>Altered cell-membrane charge with reduced drug binding</td>
</tr>
<tr>
<td>Daptomycin</td>
<td>Cell membrane</td>
<td>Produces membrane channel and membrane leakage</td>
<td>Altered cell-membrane charge with reduced drug binding</td>
</tr>
</tbody>
</table>
<h2 id="_2">抗藥性機轉<a class="headerlink" href="#_2" title="Permanent link">&para;</a></h2>
<p><img alt="resistance_zh" src="../assets/be7c385cf6d7376b54c4de4794df94d7_md5.jpeg" /><br />
<img alt="resistance_en" src="../assets/64e57133364b2f9716df1ac514b4d418_md5.jpeg" />  </p>
<h2 id="pharmakokinetics">藥物動力學 (Pharmakokinetics)<a class="headerlink" href="#pharmakokinetics" title="Permanent link">&para;</a></h2>
<ul>
<li>描述藥物在體內的分布情況  </li>
</ul>
<p>Drugs binding to serum proteins have a major influence on V<span class="arithmatex">\(_d\)</span> . Acidic drugs tend to bind to albumin and typically have lower V<span class="arithmatex">\(_d\)</span> values because they are retained in the plasma compartment. Basic drugs tend to bind to α 1 -acid glycoprotein and are retained within tissues leading to larger V<span class="arithmatex">\(_d\)</span> estimates. Protein binding is an important consideration for antimicrobial agents because unbound drug is available to exert antimicrobial activity, and in vitro methods used to assess potency through the MIC evaluate unbound drug.  </p>
<h3 id="penetrationtissue-concentration">Penetration/Tissue concentration<a class="headerlink" href="#penetrationtissue-concentration" title="Permanent link">&para;</a></h3>
<ul>
<li>過BBB: penicillin, ampicillin, oxacillin, 3rd-4th cephalosporins, moxifloxacin, vancomycin, chloramphenicol, rifampin, imipenem, meropenem, trimethoprim-sulfamethoxazole  </li>
<li>Prostatitis/epididymo-orchitis: ceftriaxone, doxycycline, fluoroquinolones, trimethoprim-sulfamethoxazole  </li>
<li>Endophthalmitis: 3rd cepha, vancomycin, triazoles, L-AMB  </li>
<li>Intracellular bacteria: lipid soluble agents (e.g. macrolides, quinolones, rifampicin)  </li>
</ul>
<h4 id="bone-penetration-for-selected-antibiotics">Bone penetration for selected antibiotics<a class="headerlink" href="#bone-penetration-for-selected-antibiotics" title="Permanent link">&para;</a></h4>
<table>
<thead>
<tr>
<th>Antibiotic</th>
<th>Range of mean bone to serum concentration ratios</th>
</tr>
</thead>
<tbody>
<tr>
<td>Levofloxacin</td>
<td>0.36-1.0</td>
</tr>
<tr>
<td>Ciprofloxacin</td>
<td>0.27-1.2</td>
</tr>
<tr>
<td>Moxifloxacin</td>
<td>0.33-1.05</td>
</tr>
<tr>
<td>Vancomycin</td>
<td>0.05-0.67</td>
</tr>
<tr>
<td>Linezolid</td>
<td>0.2-0.51</td>
</tr>
<tr>
<td>Daptomycin</td>
<td>1.17</td>
</tr>
<tr>
<td>Clindamycin</td>
<td>0.21-0.45</td>
</tr>
<tr>
<td>Cefazolin</td>
<td>0.179</td>
</tr>
<tr>
<td>Ceftriaxone</td>
<td>0.07-0.17</td>
</tr>
<tr>
<td>Cefuroxime</td>
<td>0.04-0.55</td>
</tr>
<tr>
<td>Rifampin (rifampicin)</td>
<td>0.08-0.57</td>
</tr>
</tbody>
</table>
<h2 id="pharmakodynamics">藥效動力學 (Pharmakodynamics)<a class="headerlink" href="#pharmakodynamics" title="Permanent link">&para;</a></h2>
<ul>
<li>描述藥物作用於病原體的決定因素，並與藥物動力學因素相關  </li>
</ul>
<p><img alt="PK-PD" src="../assets/0031631cc2db01c1b2049fdd7dc5c820_md5.jpg" />  </p>
<h3 id="_3">濃度依賴型抗生素<a class="headerlink" href="#_3" title="Permanent link">&para;</a></h3>
<p>這類抗生素多為抑制細菌蛋白質或核酸合成的抗生素，如aminoglycosides、fluoroquinolones，因其殺菌作用與血中濃度呈正比，為達最大之殺菌作用，建議抗生素之Cmax須高於MIC 4倍以上，且因其有抗生素後效應 (Post-antibiotic effect, PAE) 的特性，即便血中藥物濃度在給藥間隔期間內低於MIC，仍可維持一定的抗菌作用。因此採高劑量、延長給藥間隔的方式投予是比較理想的方式，once-daily aminoglycoside的給藥模式即以此理念所發展。  </p>
<h3 id="_4">時間依賴型抗生素<a class="headerlink" href="#_4" title="Permanent link">&para;</a></h3>
<p>這類抗生素多為beta-lactams類，如penicillin、cephalosporins。對penicillin和cephalosporins而言，血中藥物濃度&gt;MIC的時間越長越能滲透體內組織，建議治療期間的血中濃度有50%以上的時間高於MIC，以達療效最大化、抗生素耐藥性最小化的目標。此類藥品以連續輸注或延長輸注時間的方式給藥，除了可穩定抗生素血中濃度的變化、不增加重症患者AKI的發生率外，對整體的醫療照護支出費用也可顯著降低。  </p>
<p><img alt="continuous_infusion" src="../assets/7b65fa7dc1c088fde13f25ce0aa559f4_md5.jpg" />  </p>
<h3 id="_5">曲線下面積/最低抑菌濃度相關<a class="headerlink" href="#_5" title="Permanent link">&para;</a></h3>
<p>如vancomycin，建議血中藥物濃度之曲線下面積 (AUC) 與MIC比值達到400-600<br />
mg × h/L的目標（假設MIC為1），可確保抗生素療效與安全性。  </p>
<h2 id="_6">抗菌範圍<a class="headerlink" href="#_6" title="Permanent link">&para;</a></h2>
<p><img alt="spectrum" src="../assets/7e8b9088434a32c9d865e91bb156fd55_md5.jpeg" /><br />
<a href="http://charliekuo.com/?p=3114">Source</a>  </p>
<h3 id="anfi-fungals">Anfi-fungals<a class="headerlink" href="#anfi-fungals" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Organism</th>
<th>AmB</th>
<th>Fluconazole</th>
<th>Vori</th>
<th>Isavu</th>
<th>Anidulafungin</th>
<th>5FC</th>
</tr>
</thead>
<tbody>
<tr>
<td><em>Candida albicans</em></td>
<td>++</td>
<td>++</td>
<td>++</td>
<td>++</td>
<td>++</td>
<td>++</td>
</tr>
<tr>
<td><em>C. parapsilosis</em></td>
<td>++</td>
<td>++</td>
<td>++</td>
<td>++</td>
<td>++</td>
<td>++</td>
</tr>
<tr>
<td><em>C. tropicalis</em></td>
<td>++</td>
<td>+</td>
<td>++</td>
<td>++</td>
<td>++</td>
<td>++</td>
</tr>
<tr>
<td><em>C. glabrata</em></td>
<td>+</td>
<td>+</td>
<td>++</td>
<td>++</td>
<td>+</td>
<td>++</td>
</tr>
<tr>
<td><em>C. krusei</em></td>
<td>+</td>
<td>-</td>
<td>++</td>
<td>++</td>
<td>++</td>
<td>+</td>
</tr>
<tr>
<td><em>Cryptococcus</em> spp.</td>
<td>++</td>
<td>++</td>
<td>++</td>
<td>++</td>
<td>-</td>
<td>++</td>
</tr>
<tr>
<td><em>Aspergillus fumigatus</em></td>
<td>++</td>
<td>-</td>
<td>++</td>
<td>++</td>
<td>+</td>
<td>-</td>
</tr>
<tr>
<td><em>A. flavus</em></td>
<td>+-</td>
<td>-</td>
<td>++</td>
<td>++</td>
<td>+</td>
<td>-</td>
</tr>
<tr>
<td><em>A. terreus</em></td>
<td>-</td>
<td>-</td>
<td>++</td>
<td>++</td>
<td>+</td>
<td>-</td>
</tr>
<tr>
<td><em>A. nigger</em></td>
<td>++</td>
<td>-</td>
<td>++</td>
<td>-</td>
<td>+</td>
<td>-</td>
</tr>
<tr>
<td>Mucorales</td>
<td>++</td>
<td>-</td>
<td>-</td>
<td>++</td>
<td>-</td>
<td>-</td>
</tr>
<tr>
<td><em>Fusarium spp.</em></td>
<td>+</td>
<td>-</td>
<td>+</td>
<td>+</td>
<td>-</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3 id="mdro">MDRO<a class="headerlink" href="#mdro" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>抗藥性細菌</th>
<th>可治療藥物（粗體字為首選）</th>
</tr>
</thead>
<tbody>
<tr>
<td>Amp-C β-lactamase GNB</td>
<td>cefepime, <strong>carbapenems</strong>, fluoroquinolones, tigecycline</td>
</tr>
<tr>
<td>ESBL</td>
<td><strong>carbapenems</strong>, (ceftazidime, piperacillin/tazobactam, fluoroquinolone, trimethoprim-sulfamethoxazole, tigecycline, fosfomycin)</td>
</tr>
<tr>
<td>MRSA</td>
<td><strong>vancomycin</strong>, teicoplanin, daptomyxin, linezolid, tigecycline, minocycline, ceftaroline, trimethoprim-sulfamethoxazole, clindamycin, doxycycline, fusidic acid, rifampin</td>
</tr>
<tr>
<td>PsA</td>
<td>pip/tazo, ceftazidime, cefoperazone, cefepime, ceftazidime/avibactam, meropenem, imipenem, doripenem, ciprofloxacin, levofloxacin, aminoglycosides, cefiderocol, aztreonam</td>
</tr>
<tr>
<td>MDRAB</td>
<td>carbapenem, <strong>sulbactam</strong>, minocycline, cefiderocol, tigecycline, colistin</td>
</tr>
<tr>
<td>CRE</td>
<td>ceftazidime/avibactam, cefidericol, aminoglycosides, colistin, tigecycline, aztreonam, fosfomycin</td>
</tr>
<tr>
<td>VRE</td>
<td><strong>linezolid</strong>, daptomycin, tigecycline, fosfomycin</td>
</tr>
<tr>
<td>PRSP</td>
<td>ceftriaxone, vancomycin, teicoplanin, tigecycline</td>
</tr>
</tbody>
</table>
<p><img alt="18f9911ae8d5eb922dd432ddff4005a7_MD5.jpg" src="../assets/18f9911ae8d5eb922dd432ddff4005a7_md5.jpg" /><br />
<img alt="CRGN" src="../assets/24eb7434efb4ee8af42bd23d8cd5c0d2_md5.jpeg" />  </p>
<h3 id="_7">特殊細菌<a class="headerlink" href="#_7" title="Permanent link">&para;</a></h3>
<ul>
<li>Enterococcus: <strong>ampicillin</strong>; cephalosporins沒有效  </li>
<li>Listeria monocytogenes: <strong>ampicillin</strong>; linezolid, trimethoprim-sulfamethoxazole, penicillin, gentamicin  </li>
<li>Clostridioides difficile: metronidazole, vancomycin, fidaxomicin  </li>
<li>Pasteurella multocida: <strong>amoxicillin/clavulanic acid</strong>, penicillin, amoxicillin, cefuroxime, levofloxacin, moxifloxacin, doxycycline, trimethoprim-sulfamethoxazole  </li>
<li>Neisseria gonorrhoeae: <strong>ceftriaxone</strong>  </li>
<li>Neisseria meningitides: <strong>penicillin</strong>; ceftriaxone  </li>
<li>Salmonella spp.: <strong>ceftriaxone</strong>, fluoroquinolone  </li>
<li>Vibrio: tetracyclines, fluoroquinolone, trimethoprim-sulfamethoxazole  </li>
<li>Stenotrophomonas maltophila: <strong>trimethoprim-sulfamethoxazole</strong>; levofloxacin, minocycline, colistin, cefiderocol  </li>
<li>Burkholderia pseudomallei: ceftazidime, meropenem, imipenem  </li>
<li>Legionella: azithromycin or quinolone  </li>
<li>Treponema pallidum: penicillin; ceftriaxone, doxycycline  </li>
<li>Mycoplasma pneumoniae: tetracyclines, erythromycin  </li>
<li>Chlamydia spp.: tetracyclines, azithromycin  </li>
<li>Anaerobes: <strong>metronidazole</strong>, amp/sulb, pip/tazo, cephamycin, carbapenems, clindamycin, moxifloxacin, tigecycline  </li>
</ul>
<h3 id="drugs-of-choices">Drugs of choices<a class="headerlink" href="#drugs-of-choices" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>ANTIMICROBIAL(S)</th>
<th>INFECTIONS</th>
<th>COMMON PATHOGENS (% SUSCEPTIBLE); RESISTANCE AS NOTED[^a]</th>
</tr>
</thead>
<tbody>
<tr>
<td>Penicillin G</td>
<td>梅毒；yaws；鉤端螺旋體病；鏈球菌感染；肺炎鏈球菌感染；放線菌病；口腔和牙周感染；流行性腦膜炎及腦膜炎雙球菌血症；草綠色鏈球菌心內膜炎；梭狀芽孢桿菌性肌壞死；破傷風；鼠咬熱；Pasteurella multocida 感染；丹毒（Erysipelothrix rhusiopathiae）</td>
<td><em>Neisseria meningitidis</em>; viridans streptococci (69%); <em>Streptococcus pneumoniae</em> (97% nonmeningitis; 75% meningitis)</td>
</tr>
<tr>
<td>Ampicillin, amoxicillin</td>
<td>Salmonellosis; 急性中耳炎; <em>Haemophilus influenzae</em> 腦膜炎和會厭炎 ; <strong><em>Listeria monocytogenes</em> 腦膜炎; <em>Enterococcus faecalis</em> UTI</strong></td>
<td><em>Escherichia coli</em> (51%); <em>H. influenzae</em> (70%); <em>Salmonella</em> spp. (85%)</td>
</tr>
<tr>
<td>Nafcillin, oxacillin</td>
<td><strong>MSSA</strong>菌血症和心內膜炎</td>
<td><em>Staphylococcus aureus</em> (70%); coagulase-negative staphylococci (50%)</td>
</tr>
<tr>
<td>Piperacillin-tazobactam</td>
<td>腹腔內感染（兼性腸道革蘭氏陰性桿菌和絕對厭氧菌）；混合菌叢引起的感染（吸入性肺炎、糖尿病足潰瘍）；由 Pseudomonas aeruginosa 引起的感染</td>
<td><em>P. aeruginosa</em> (82%)</td>
</tr>
<tr>
<td>Cefazolin</td>
<td>E. coli UTI；手術預防；MSSA 菌血症和心內膜炎</td>
<td><em>E. coli</em> (82%)</td>
</tr>
<tr>
<td>Cefoxitin, cefotetan</td>
<td>腹腔內感染和骨盆炎性疾病</td>
<td><em>Bacteroides fragilis</em> (60%)[^b]</td>
</tr>
<tr>
<td>Ceftriaxone</td>
<td>淋病；肺炎鏈球菌腦膜炎；草綠色鏈球菌心內膜炎；沙門氏菌病和傷寒；由非<em>Pseudomonas aeruginosa</em>引起的院內感染</td>
<td><em>S. pneumoniae</em> (91% meningitis; 99% nonmeningitis); <em>E. coli</em> (90%); <em>Klebsiella pneumoniae</em> (88%)</td>
</tr>
<tr>
<td>Ceftazidime, cefepime</td>
<td>由兼性革蘭氏陰性桿菌和 <em>Pseudomonas</em> spp. 引起的院內感染</td>
<td><em>P. aeruginosa</em> (86%)</td>
</tr>
<tr>
<td>Ceftaroline</td>
<td><em>S. pneumoniae</em>, MSSA, <em>H. influenzae, K. pneumoniae, Klebsiella oxytoca, E. coli</em>引起的CAP；由 MSSA, MRSA, <em>Streptococcus pyogenes, Streptococcus agalactiae, E. coli, K. pneumoniae, K. oxytoca</em> 引起的急性細菌性皮膚及皮膚結構感染</td>
<td>大多數對 Ceftaroline 敏感；來自單一希臘醫院的四株 MRSA 分離株對 Ceftaroline 的 MIC &gt;4 μg/mL[^c]；其他個案報告，包括在未曾接觸 ceftaroline 的患者[^d,e]</td>
</tr>
<tr>
<td>Ceftazidime-avibactam, meropenem-vaborbactam</td>
<td>由抗藥性革蘭氏陰性菌（包括 <em>Pseudomonas</em> 和一些厭氧菌）引起的複雜性尿路感染和複雜性腹腔內感染（ceftazidime-avibactam 與 metronidazole 併用）</td>
<td><em>P. aeruginosa</em> (84–97%)[^f]<br><br>MDR Enterobacterales, including carbapenem-resistant Enterobacterales that produce KPCs<br><br>No activity against metallo-β-lactamases (e.g., NDM)</td>
</tr>
<tr>
<td>Imipenem, meropenem</td>
<td>由 <em>Enterobacter</em> spp. 和產生 ESBL 的革蘭氏陰性桿菌引起的腹腔內感染</td>
<td><em>P. aeruginosa</em> (84%); <em>Acinetobacter calcoaceticus-baumannii</em> complex (85%) (meropenem susceptibilities reported)</td>
</tr>
<tr>
<td>Ertapenem</td>
<td>CAP；複雜性尿路感染，包括腎盂腎炎；急性骨盆感染；複雜性腹腔內感染；複雜性皮膚和皮膚結構感染，不包括伴有骨髓炎或由 <em>P. aeruginosa</em> 引起的糖尿病足感染</td>
<td><em>Enterobacter cloacae</em> (90%); <em>K. pneumoniae</em> (98%)</td>
</tr>
<tr>
<td>Aztreonam</td>
<td>對penicillin過敏患者由兼性革蘭氏陰性桿菌和 <em>Pseudomonas</em> 引起的感染</td>
<td><em>P. aeruginosa</em> (69%)</td>
</tr>
<tr>
<td>Vancomycin</td>
<td>由 MRSA 引起的菌血症、心內膜炎和其他侵襲性疾病；肺炎鏈球菌腦膜炎；口服製劑用於 CDAD</td>
<td><em>S. aureus</em> (100%); <em>E. faecalis</em> (96%); <em>E. faecium</em> (34%)</td>
</tr>
<tr>
<td>Daptomycin</td>
<td>VRE 感染；MRSA 菌血症</td>
<td><em>E. faecalis</em> (99.9%)[^i]; <em>E. faecium</em> (99.7%)[^i]; <em>S. aureus</em> (99.9%)[^g]</td>
</tr>
<tr>
<td>Gentamicin, amikacin, streptomycin, tobramycin</td>
<td>與penicillin併用治療葡萄球菌、腸球菌或鏈球菌心內膜炎；與 β-lactam類併用治療革蘭氏陰性菌血症；腎盂腎炎</td>
<td><em>E. coli</em> (gentamicin, 91%); <em>P. aeruginosa</em> (amikacin, 82%; gentamicin, 84%); <em>A. calcoaceticus-baumannii</em> complex (gentamicin, 89%)</td>
</tr>
<tr>
<td>Azithromycin, clarithromycin, erythromycin</td>
<td><em>Legionella, Campylobacter</em>, <em>Mycoplasma</em> 感染；CAP；對penicillin過敏患者的A型鏈球菌咽喉炎；細菌性血管瘤病；<em>Helicobacter pylori</em>；鳥型分枝桿菌感染</td>
<td><em>S. pneumoniae</em> (60%); group A streptococci (82%); <em>H. pylori</em> (75%)j</td>
</tr>
<tr>
<td>Clindamycin</td>
<td>嚴重、侵襲性的A型鏈球菌感染（與 β-lactam合用）；由絕對厭氧菌引起的感染；由敏感的葡萄球菌引起的感染</td>
<td><em>S. aureus</em> (70%)</td>
</tr>
<tr>
<td>Doxycycline, minocycline</td>
<td>慢性支氣管炎的急性細菌性加重；輕度CAP；MRSA皮膚和軟組織感染；<em>Vibrio vulnificus</em> 感染；披衣菌 (doxycycline)；Rickettsia感染（恙蟲病、斑疹傷寒）；penicillin過敏者治療放線菌感染；<strong>鉤端螺旋體感染；梅毒；類鼻疽</strong>；鼻疽；鼠疫；布魯氏菌病（與streptomycin合用）；兔熱病；萊姆病 (doxycycline)；腹股溝肉芽腫<br><br> <strong><em>Stenotrophomonas, Mycobacterium marinum</em></strong>感染 (minocycline)<br><mark>健保給付僅限對CRAB</mark></td>
<td><em>S. pneumoniae</em> (63%); <em>S. aureus</em> (97%)</td>
</tr>
<tr>
<td>Tigecycline</td>
<td>由 <em>S. pneumoniae, H. influenzae</em>, or <em>Legionella pneumophila</em> 引起的CAP；由 <em>E. coli</em>, vancomycin-susceptible <em>E. faecalis, Citrobacter freundii, E. cloacae, K. pneumoniae, K. oxytoca, Bacteroides</em> spp., <em>Clostridium perfringens</em>, and <em>Peptostreptococcus</em> spp.多重抗藥革蘭氏陰性菌和厭氧菌引起的複雜性腹腔內感染；由 <em>E. coli</em>, MRSA, MSSA, <em>S. pyogenes, Streptococcus anginosus, S. agalactiae, B. fragilis</em> 引起的複雜性皮膚和軟組織感染</td>
<td>Mostly susceptible, although case reports of resistance in <em>A. baumannii</em> and <em>K. pneumoniae</em></td>
</tr>
<tr>
<td>TMP-SMX</td>
<td>社區性UTI和社區性MRSA皮膚和軟組織感染</td>
<td><em>E. coli</em> (73%); <em>S. aureus</em> (95%)</td>
</tr>
<tr>
<td>Ciprofloxacin, levofloxacin, moxifloxacin, delafloxacin</td>
<td>CAP (levofloxacin and moxifloxacin); UTI; <em>Pseudomonas</em> infections (ciprofloxacin and levofloxacin)；醫院獲得性革蘭氏陰性腸道感染；細菌性腸胃炎</td>
<td><em>S. pneumoniae</em> (99% levofloxacin); <em>E. coli</em> (79% for ciprofloxacin and levofloxacin); <em>P. aeruginosa</em> (ciprofloxacin, 76%; levofloxacin, 70%); <strong><em>Salmonella</em> spp.</strong> (72% for ciprofloxacin and levofloxacin)</td>
</tr>
<tr>
<td>Rifampin</td>
<td><strong>葡萄球菌異物感染（與其他抗葡萄球菌藥物聯合使用）; <em>Legionella</em> pneumonia</strong>; <em>Mycobacterium tuberculosis</em>; atypical nontuberculous mycobacterial infection</td>
<td><em>S. aureus</em> (99%), although staphylococci rapidly develop resistance with monotherapy</td>
</tr>
<tr>
<td>Metronidazole</td>
<td>絕對厭氧革蘭氏陰性菌（如 Bacteroides spp.）；肺、腦或腹部膿瘍；細菌性陰道炎；CDAD</td>
<td>Mostly susceptible; resistance very rare</td>
</tr>
<tr>
<td>Linezolid, tedizolid</td>
<td>VRE; 由 MSSA 和 MRSA 引起的皮膚及軟組織感染；伴有菌血症的CAP；HAP</td>
<td>Mostly susceptible; resistance occasionally seen in VRE</td>
</tr>
<tr>
<td>Colistin</td>
<td>由對其他所有治療方案耐藥的革蘭氏陰性桿菌引起的感染 (如 <em>P. aeruginosa, Acinetobacter</em> spp., and <em>Stenotrophomonas maltophilia</em>)</td>
<td><em>P. aeruginosa</em> (case reports, outbreaks)</td>
</tr>
<tr>
<td>Nitrofurantoin</td>
<td>大多數革蘭氏陰性桿菌和一些革蘭氏陽性菌引起的UTI；反復性膀胱炎的預防</td>
<td><em>E. coli</em> (95%); <em>E. faecalis</em> (99%)</td>
</tr>
<tr>
<td>Fosfomycin</td>
<td>大多數革蘭氏陰性桿菌和一些革蘭氏陽性菌引起的尿路感染；反復性膀胱炎的預防</td>
<td>被認為是低抗藥性</td>
</tr>
<tr>
<td>Cefiderocol</td>
<td>由多重抗藥革蘭氏陰性菌引起的複雜性尿路感染和/或腎盂腎炎，包括產生ESBL或carbapenemase的細菌以及多重抗藥性<em>Pseudomonas aeruginosa, Acinetobacter baumannii, Stenotrophomonas maltophilia, Burkholderia cepacia complex</em></td>
<td>初步研究中顯示抗藥機率非常低</td>
</tr>
</tbody>
</table>
<h2 id="_8">本院有的抗生素<a class="headerlink" href="#_8" title="Permanent link">&para;</a></h2>
<h3 id="cephalosporins">Cephalosporins<a class="headerlink" href="#cephalosporins" title="Permanent link">&para;</a></h3>
<p>第一代：Cefazolin, cephalexin (PO)<br />
第二代：Cefuroxime (IV, PO)<br />
第三代：Ceftriaxone, ceftazidime, cefoperazone/sulbactam, ceftazidime/avibactam, cefixime (PO)<br />
第四代：Cefepime<br />
第五代：Ceftaroline  </p>
<h3 id="penicillins">Penicillins<a class="headerlink" href="#penicillins" title="Permanent link">&para;</a></h3>
<p>Penicillin G, penicillin benzathine (IM)<br />
Oxacillin, dicloxacillin (PO)<br />
Ampicillin, ampicillin/sulbactam<br />
Amoxicillin, amoxicillin/clavulanic acid (PO)<br />
Piperacillin, piperacillin/tazobactam  </p>
<h3 id="carbapenems">Carbapenems<a class="headerlink" href="#carbapenems" title="Permanent link">&para;</a></h3>
<p>Ertapenem, imipenem/cilastatin, meropenem  </p>
<h3 id="aminoglycosides">Aminoglycosides<a class="headerlink" href="#aminoglycosides" title="Permanent link">&para;</a></h3>
<p>Gentamicin, amikacin  </p>
<h3 id="fluoroquinolones">Fluoroquinolones<a class="headerlink" href="#fluoroquinolones" title="Permanent link">&para;</a></h3>
<p>Moxifloxacin, ciprofloxacin, levofloxacin (IV, PO)  </p>
<h3 id="tetracyclines">Tetracyclines<a class="headerlink" href="#tetracyclines" title="Permanent link">&para;</a></h3>
<p>Tetracycline (PO), doxycycline (PO), tigecycline, minocycline  </p>
<h3 id="macrolides">Macrolides<a class="headerlink" href="#macrolides" title="Permanent link">&para;</a></h3>
<p>Azithromycin (PO), clarithromycin (PO), erythromycin  </p>
<h3 id="glycopeptides-lipoglycopeptides-daptomycin-oxazolidinones">Glycopeptides, lipoglycopeptides, daptomycin, oxazolidinones<a class="headerlink" href="#glycopeptides-lipoglycopeptides-daptomycin-oxazolidinones" title="Permanent link">&para;</a></h3>
<p>Vancomycin, teicoplanin, daptomycin, linezolid (IV, PO)  </p>
<h3 id="other-anti-bacterials">Other anti-bacterials<a class="headerlink" href="#other-anti-bacterials" title="Permanent link">&para;</a></h3>
<p>Clindamycin (PO)<br />
Fosfomycin (IV, PO)<br />
Trimethoprim-sulfamethoxazole (PO)<br />
Colistin<br />
Metronidazole (IV, PO)<br />
Rifampin, isoniazid, ethambutol, pyrazinamide (PO)  </p>
<h3 id="anti-fungals">Anti-fungals<a class="headerlink" href="#anti-fungals" title="Permanent link">&para;</a></h3>
<p>Fluconazole (IV, PO): 對<em>Aspergillus spp., Candida krusei</em>無效; <em>Candida glabrata, Candida tropicalis</em>也可能沒效<br />
Voriconazole (IV, PO)<br />
Isavuconazole<br />
Anidulafungin<br />
Amphotericin B liposome  </p>
<h2 id="_9">孕婦<a class="headerlink" href="#_9" title="Permanent link">&para;</a></h2>
<ul>
<li>不建議使用aminoglycosides, tetracyclines  </li>
<li>Metronidazole, trimethoprim-sulfamethoxazole第一孕期禁用  </li>
</ul>
<h2 id="_10">常見副作用<a class="headerlink" href="#_10" title="Permanent link">&para;</a></h2>
<h3 id="ampicillinsulbactam">Ampicillin/sulbactam<a class="headerlink" href="#ampicillinsulbactam" title="Permanent link">&para;</a></h3>
<ul>
<li>腹瀉  </li>
<li>偽膜性腸炎  </li>
</ul>
<h3 id="piperacillintazobactam">Piperacillin/tazobactam<a class="headerlink" href="#piperacillintazobactam" title="Permanent link">&para;</a></h3>
<ul>
<li>腎毒性  </li>
<li>腸道菌群失衡（可能導致偽膜性腸炎）  </li>
<li>血小板減少症  </li>
</ul>
<h3 id="ceftriaxone">Ceftriaxone<a class="headerlink" href="#ceftriaxone" title="Permanent link">&para;</a></h3>
<ul>
<li>肝毒性、黃疸  </li>
<li>不可加入含鈣之點滴注射液  </li>
</ul>
<h3 id="cefepime">Cefepime<a class="headerlink" href="#cefepime" title="Permanent link">&para;</a></h3>
<ul>
<li>神經毒性（尤其是在腎功能受損的病人中，可能引起癲癇）  </li>
</ul>
<h3 id="carbapenems_1">Carbapenems<a class="headerlink" href="#carbapenems_1" title="Permanent link">&para;</a></h3>
<ul>
<li>神經毒性（特別是在高劑量或腎功能不全時）  </li>
</ul>
<h3 id="aminoglycosides-gentamicin">Aminoglycosides (Gentamicin)<a class="headerlink" href="#aminoglycosides-gentamicin" title="Permanent link">&para;</a></h3>
<ul>
<li>腎毒性：preexisting renal impairment, concomitant nephrotoxic medications, advanced age and dehydration  </li>
<li>耳毒性（可能引起聽力損失或平衡障礙）：proportional to the amount of drug given and the duration of treatment; tinnitus or vertigo may be indications of vestibular injury and impending bilateral irreversible damage  </li>
<li>神經肌肉阻礙、呼吸衰竭  </li>
</ul>
<h3 id="sulfamethoxazoletrimethoprim-tmp-smx">Sulfamethoxazole/Trimethoprim (TMP-SMX)<a class="headerlink" href="#sulfamethoxazoletrimethoprim-tmp-smx" title="Permanent link">&para;</a></h3>
<ul>
<li>高血鉀  </li>
<li>腎毒性  </li>
<li>肝毒性  </li>
<li>過敏反應  </li>
<li>骨髓抑制（可能引起貧血、白血球減少、血小板減少）  </li>
</ul>
<h3 id="vancomycin">Vancomycin<a class="headerlink" href="#vancomycin" title="Permanent link">&para;</a></h3>
<ul>
<li>腎毒性  </li>
<li>耳毒性  </li>
<li>嗜中性球低下、白血球減少、血小板減少  </li>
<li><mark><strong>Red man syndrome</strong></mark>：與vancomycin的劑量有所關聯，特別是發生在劑量較大且快速滴注時。主要是由皮膚、肺、腸胃道、心肌及血管系統中的<strong>肥大細胞</strong>及嗜鹼性白血球釋出<strong>組織胺</strong>所導致的。此現象通常發生在首次的給予劑量，但也可能會發生在任何一個給藥時間。一般常見的典型的症狀為<strong>上半身軀幹</strong>有潮紅、紅疹、蕁麻疹及搔癢之現象，在幾個比較嚴重的案例中曾發現低血壓、胸痛及呼吸窘迫之症狀。  </li>
<li>全身性過敏反應：是一種急性且危及生命的免疫反應，一般發生非常迅速，通常在給藥後之5-30分鐘以內發作。首先病人會對vancomycin敏感而在體內產生vancomycin特異性的IgE（vancomycin-specific IgE）。若對產生過敏之病人重複投予vancomycin會造成敏感性肥大細胞上的IgE接受器產生交叉連結反應，而引起血管活化調節物質的釋出，這些物質例如有組織胺、白三稀素C4（leukotriene C4）、前列腺素（prostaglandin D2）及細胞介質素，例如：腫瘤壞死因子（TNF-a）及interleukin 4, 5, 6, 7, 8及13。因為這些物質之釋出而擴大vancomycin之過敏反應進而產生血管擴張作用引起全身性皮膚紅疹、搔癢、蕁麻疹、支氣管收縮、腸道過度蠕動、低血壓或心律不整。  </li>
</ul>
<h3 id="daptomycin">Daptomycin<a class="headerlink" href="#daptomycin" title="Permanent link">&para;</a></h3>
<ul>
<li>肌肉病變（myopathy）  </li>
<li>Drug-induced eosinophilic pneumonia（少見）  </li>
<li>Do not use for primary pneumonia: inactivated by pulmonary surfactant  </li>
</ul>
<h3 id="linezolid">Linezolid<a class="headerlink" href="#linezolid" title="Permanent link">&para;</a></h3>
<ul>
<li>肝毒性  </li>
<li>血球低下（使用兩周以上）  </li>
<li>不可與單胺氧化酶抑制劑(monoamine oxidase inhibitor)或selective serotonin re-uptake inhibitor共同使用（serotonin syndrome）  </li>
<li>視神經病變  </li>
<li>乳酸中毒（少見）  </li>
</ul>
<h3 id="clindamycin">Clindamycin<a class="headerlink" href="#clindamycin" title="Permanent link">&para;</a></h3>
<ul>
<li>腹瀉  </li>
<li>偽膜性腸炎（由困難梭狀桿菌引起）  </li>
<li>皮疹  </li>
<li>肝毒性  </li>
</ul>
<h3 id="tetracyclines-doxycycline-minocycline">Tetracyclines (如doxycycline, minocycline)<a class="headerlink" href="#tetracyclines-doxycycline-minocycline" title="Permanent link">&para;</a></h3>
<ul>
<li>光感受性  </li>
<li>胃腸不適  </li>
<li>骨骼和牙齒發育障礙（特別是在兒童中）  </li>
<li>肝毒性  </li>
<li>併用Warfarin會加強Warfarin抗凝血功能增加出血的風險  </li>
</ul>
<h3 id="fluoroquinolones_1">Fluoroquinolones<a class="headerlink" href="#fluoroquinolones_1" title="Permanent link">&para;</a></h3>
<ul>
<li>QTc 延長  </li>
<li>肌腱炎及肌腱斷裂、關節病變（兒童不適合使用，老年人和同時用steroid的人使用fluoroquinolone會增加此副作用之風險）  </li>
<li>血糖異常（高血糖或低血糖）  </li>
<li>與aortic aneurysm or dissection可能有關  </li>
</ul>
<h3 id="macrolides_1">Macrolides<a class="headerlink" href="#macrolides_1" title="Permanent link">&para;</a></h3>
<ul>
<li>胃腸道不適（如腹瀉、噁心）  </li>
<li>QTc 延長  </li>
<li>肝毒性  </li>
</ul>
<h3 id="metronidazole">Metronidazole<a class="headerlink" href="#metronidazole" title="Permanent link">&para;</a></h3>
<ul>
<li>腸胃不適（如噁心、嘔吐）  </li>
<li>周邊神經病變（長期使用）  </li>
<li>口腔金屬味  </li>
<li>酒精不耐受反應  </li>
</ul>
<h3 id="fluconazole">Fluconazole<a class="headerlink" href="#fluconazole" title="Permanent link">&para;</a></h3>
<ul>
<li>QTc 延長  </li>
<li>肝毒性  </li>
</ul>
<h3 id="amphotericin-b">Amphotericin B<a class="headerlink" href="#amphotericin-b" title="Permanent link">&para;</a></h3>
<ul>
<li>腎毒性  </li>
<li>低血鉀  </li>
<li>輸注反應：發燒、寒顫、頭痛、心搏過速  </li>
</ul>
<h2 id="_11">考古題<a class="headerlink" href="#_11" title="Permanent link">&para;</a></h2>
<h3 id="_12">專師<a class="headerlink" href="#_12" title="Permanent link">&para;</a></h3>
<ol>
<li>
<p>病危的病人因 Pseudomonas aeruginosa 引起之肺炎，優先選擇之抗生素不包括下列何者？ <a href="#medicine/antibiotics">#medicine/antibiotics</a>  <br />
    (A) Cefepime®  <br />
    (B) Piperacillin/tazobactam®  <br />
    (C) Meropenem®  <br />
<mark>(D) Ampicillin/sulbactam®</mark>  </p>
</li>
<li>
<p>關於 aminoglycoside 副作用之敘述，下列何者錯誤？ <a href="#medicine/antibiotics">#medicine/antibiotics</a>  <br />
    (A) 應保持良好水化以預防腎毒性  <br />
<mark>(B) 一般治療劑量下不會引起耳毒性</mark>  <br />
    (C) 年紀大病人較易發生腎毒性  <br />
    (D) 停藥後須繼續監測聽力約 3-4 週  </p>
</li>
<li>
<p>針對反覆泌尿道感染治療的抗生素，下列何者具抑制乙醯輔酶 A 的作用？ <a href="#medicine/antibiotics">#medicine/antibiotics</a>  <br />
<mark>(A) nitrofurantoin</mark>  <br />
    (B) trimethoprim  <br />
    (C) sulfamethoxazole  <br />
    (D) sulfisomidine  </p>
</li>
<li>
<p>下列抗生素與副作用之組合，何者最不適當？ <a href="#medicine/antibiotics">#medicine/antibiotics</a>  <br />
    (A) vancomycin – 腎毒性  <br />
<mark>(B) gentamicin – 低血鉀</mark>  <br />
    (C) clindamycin – 腹瀉、偽膜性腸炎  <br />
    (D) tetracycline – 光感受性( photosensitivity )  </p>
</li>
<li>
<p>vancomycin 引起相關red man syndrome 副作用，下列敘述何者正確？ <a href="#medicine/antibiotics">#medicine/antibiotics</a>  <br />
    (A) 主要與遺傳有關  <br />
    (B) 為自體免疫複合物反應  <br />
    (C) 特點為臉部潮紅、四肢出現紅疹，但軀幹正常  <br />
<mark>(D) 與靜脈滴注藥物時間太快有關，可能引起心跳驟停</mark>  </p>
</li>
<li>
<p>下列何種抗生素在慢性腎衰竭病人不需要減量使用？ <a href="#medicine/antibiotics">#medicine/antibiotics</a>  <br />
<mark>(A) macrolide，如erythromycin</mark>  <br />
    (B) aminoglycoside，如gentamicin  <br />
    (C) polymyxin，如colistin  <br />
    (D) sulfar drug，如TMP - SMX  </p>
</li>
</ol>
<h3 id="_13">通論<a class="headerlink" href="#_13" title="Permanent link">&para;</a></h3>
<ol>
<li>
<p>下列感染症及對應治療抗生素的組合，何者最不適當？ <a href="#medicine/antibiotics">#medicine/antibiotics</a>  <br />
    (A) 立克次體感染– doxycycline  <br />
    (B) 偽膜性腸炎– metronidazole  <br />
    (C) 李斯特菌感染– ampicillin  <br />
<mark>(D) 沙門氏菌血症– cefazolin</mark>  </p>
</li>
<li>
<p>有關fluoroquinolones 的副作用，下列何者最不可能？ <a href="#medicine/antibiotics">#medicine/antibiotics</a>  <br />
    (A) 心電圖QTc 延長  <br />
    (B) 肌腱炎( tendinitis )  <br />
    (C) 血糖異常( dysglycemia )  <br />
<mark>(D) 光敏感( photosensitivity )</mark>  </p>
</li>
<li>
<p>年輕女性已懷孕3 個月罹患泌尿道感染，不宜使用下列何種抗生素？ <a href="#medicine/antibiotics">#medicine/antibiotics</a>  <br />
<mark>(A) fluoroquinolone</mark>  <br />
    (B) nitrofurantoin  <br />
    (C) ampicillin  <br />
    (D) cefazolin  </p>
</li>
</ol>
<h3 id="_14">外科<a class="headerlink" href="#_14" title="Permanent link">&para;</a></h3>
<ol>
<li>
<p>下列廣效性抗生素中，何者是屬於干擾細胞壁合成胜肽類相互交叉連接(transpeptidation) ，以達殺菌效果？ <a href="#medicine/antibiotics">#medicine/antibiotics</a>  <br />
    (A) aminoglycosides 類  <br />
<mark>(B) β-lactam 類</mark>  <br />
    (C) quinolones 類  <br />
    (D) tetracyclines 類  </p>
</li>
<li>
<p>下列那一種藥物最適用於治療Pseudomonas aeruginosa 引起的腦膜炎？ <a href="#medicine/antibiotics">#medicine/antibiotics</a>  <br />
<mark>(A) cefepime</mark>  <br />
    (B) cephalothin  <br />
    (C) cefoxitin  <br />
    (D) cefuroxime  </p>
</li>
<li>
<p>下列抗生素與副作用之組合，何者最不適當？ <a href="#medicine/antibiotics">#medicine/antibiotics</a>  <br />
    (A) vancomycin –腎毒性  <br />
    (B) clindamycin – 腹瀉、偽膜性腸炎  <br />
<mark>(C) gentamicin – 低血鉀</mark>  <br />
    (D) tetracycline – 光感受性(photosensitivity)  </p>
</li>
<li>
<p>下列抗微生素製劑與副作用之組合，何者最不適當？ <a href="#medicine/antibiotics">#medicine/antibiotics</a>  <br />
    (A) daptomycin–myopathy（肌肉病變）  <br />
    (B) chloramphenicol–aplastic anemia（再生不良性貧血）  <br />
<mark>(C) gentamicin-hepatic failure（肝衰竭）</mark> <code>腎衰竭</code>  <br />
    (D) tetracycline-photosensitivity（光敏感症）  </p>
</li>
<li>
<p>下列何種抗生素的使用較不易造成QT 延長？ <a href="#medicine/antibiotics">#medicine/antibiotics</a>  <br />
    (A) ciprofloxacin  <br />
<mark>(B) cefepime</mark>  <br />
    (C) azithromycin  <br />
    (D) fluconazole  </p>
</li>
<li>
<p>敗血症致病原與抗生素治療的配對，下列何者錯誤？ <a href="#medicine/antibiotics">#medicine/antibiotics</a>  <br />
    (A) neisseria meningitidis ( 腦膜炎雙球菌) - ceftriaxone  <br />
<mark>(B) enterococcus ( 腸球菌) - cefazolin</mark>  <br />
    (C) methicillin - resistant staphylococcus aureus(methicillin抗藥性金黃色葡萄球菌) - daptomycin  <br />
    (D) anaerobes ( 厭氧菌) - metronidazole  </p>
</li>
<li>
<p>關於抗微生物製劑，下列敘述何者正確？ <a href="#medicine/antibiotics">#medicine/antibiotics</a>  <br />
<mark>(A) ciprofloxacin hcl 一般對綠膿桿菌 ( <em>P. aeruginosa</em> ) 有很好的治療效果</mark>  <br />
    (B) clindamycin 可用於治療艱難梭菌 ( <em>C. difficile</em> ) 造成的腹瀉  <br />
    (C) linezolid 因口服吸收率低，需要靜脈輸注使用  <br />
    (D) rifampin 的副作用以噁心及嘔吐最為常見  </p>
</li>
<li>
<p>一位 55 歲 60 kg 女性，因膽囊結石反覆發炎而入院接受腹腔鏡膽囊切除術，下列術前預防性抗生素及投注劑量何者正確？ <a href="#medicine/antibiotics">#medicine/antibiotics</a>  <br />
    (A) ampicillin 1 g  <br />
<mark>(B) cefazolin 2 g</mark>  <br />
    (C) cefuroxime 3 g  <br />
    (D) fluoroquinolone 0.5 g  </p>
</li>
</ol>
<h3 id="_15">內科醫師<a class="headerlink" href="#_15" title="Permanent link">&para;</a></h3>
<ol>
<li>
<p>有關抗生素之描述，下列哪一項不正確? <a href="#medicine/antibiotics">#medicine/antibiotics</a>  <br />
    A. Fluoroquinolone類抗生素在QTc prolongation的病人產生心律不整的風險增加  <br />
    B. 老年人和同時用steroid的人使用fluoroquinolone會增加tendinitis副作用之風險  <br />
    C. 懷孕婦人不建議使用streptomycin，tetracycline或tigecycline (category D)  <br />
    D. 使用ceftriaxone不可加入含鈣之點滴注射液  <br />
    ==E. Fluoroquinolone對MRSA及VRE治療效果良好 ==  </p>
</li>
<li>
<p>有關腸球菌與抗生素之敘述，請選出最正確的答案 <a href="#medicine/antibiotics">#medicine/antibiotics</a>  <br />
    (1) Vancomycin抗藥性腸球菌 (VRE) 最常見的菌種是Enterococcus faecium  <br />
    (2) Enterococcus faecalis菌血症通常以 vancomycin治療  <br />
    (3) Enterococcus faecails感染的首選治療通常是 ampicillin  <br />
    (4) VRE的嚴重感染常需使用linezolid或daptomycin治療  <br />
    (5) 尿液培養或痰液培養有VRE，需使用linezolid治療  <br />
    A. (1)+(2)  <br />
    B. (1)+(3)  <br />
    C. (2)+(4)  <br />
<mark>D. (1)+(3)+(4)</mark>  <br />
    E. (1)+(2)+(3)+(4)+(5)  </p>
</li>
<li>
<p>下列用於治療methicillin-resistant Staphylococcus aureus (MRSA)之敘述何者正確？ <a href="#medicine/antibiotics">#medicine/antibiotics</a>  <br />
    A. MRSA與 methicillin-susceptible Staphylococcus aureus (MSSA) 心內膜炎死亡率相近  <br />
    B. 只有院內感染才有MRSA的風險，一般社區型肺炎不應將MRSA列入考量  <br />
    C. Tigecycline屬於殺菌型藥物，可用於心內膜炎及菌血症之治療，高劑量使用須注意腸胃道症狀  <br />
<mark>D. Linezolid長時間使用可能會造成血小板數量降低，也可能引發視神經病變，須注意眼底檢查</mark>  <br />
    E. Vancomycin使用時只須監測血中 trough 濃度，以評估其療效及副作用  </p>
</li>
<li>
<p>有關抗生素治療與敗血症致病原的配對,下列哪些組合是正確的？ <a href="#medicine/antibiotics">#medicine/antibiotics</a>  <br />
    (1) Ceftriaxone - Neisseria meningitidis   <br />
    (2) Penicillin - Group A Streptococcus   <br />
    (3) Clindamycin - Rickettsia   <br />
    (4) Ceftazidime- Enterococcus  <br />
<mark>A. (1)+(2)</mark>  <br />
    B. (2)+(3)  <br />
    C. (1)+(3)  <br />
    D. (2)+(4)  <br />
    E. (1)+(4)  </p>
</li>
<li>
<p>一位83歲男性，因為尿路感染併菌血症而住進加護病房。三天前他因為間斷性神智混亂、虛弱，解尿疼痛和血尿被送到急診，因為血流動力情況不穩而入住加護病房，剛開始接受靜脈輸液，經驗性meropenem。三天後低血壓和發燒都緩解，身體診察體溫37.6°C，血壓120/80 mmHg，心跳94/min，呼吸18/min，心臟診察正常，腰側和腹部無壓痛，尿液培養Enterococcus faecalis大於100000菌落，而血液培養也是E. faecalis，抗生素感染性試驗對ampicillin，vancomycin和gentamicin具敏感性。 請問此時下列哪一項抗生素治療是適當的? <a href="#medicine/antibiotics">#medicine/antibiotics</a>  <br />
<mark>A. 改成ampicillin</mark>  <br />
    B. 改成ampicillin和gentamicin  <br />
    C. 改成vancomycin  <br />
    D. 改成vancomycin和gentamicin  <br />
    E. 繼續使用meropenem  </p>
</li>
<li>
<p>有關致病原感染與抗生素治療的配對,下列哪些組合是正確的? (1) Bacteroides - metronidazole (2) Meningococcus - ceftriaxone (3) Staphylococcus - vancomycin or oxacillin (4) Enterococcus - cefazolin <a href="#medicine/antibiotics">#medicine/antibiotics</a>  <br />
<mark>A. (1)+(2)+(3)</mark>  <br />
    B. (2)+(3)+(4)  <br />
    C. (1)+(3)+(4)  <br />
    D. (1)+(2)+(4)  <br />
    E. (1)+(2)+(3)+(4)  </p>
</li>
<li>
<p>有關A族鏈球菌造成的急性咽喉炎(pharyngitis)之敘述，以下有關治療之敘述何者不正確？ <a href="#medicine/antibiotics">#medicine/antibiotics</a>  <br />
    A. 治療可降低風濕熱之風險  <br />
    B. 治療可縮短疾病症狀  <br />
    C. 可降低對密切接觸者或在擁擠環境中之傳播  <br />
    D. 治療可採10天之口服Amoxicillin  <br />
<mark>E. 治療採moxifloxacin 7天</mark>  </p>
</li>
<li>
<p>一般對綠膿桿菌感染的治療可選下列哪些抗生素? (1) Moxifloxacin (2) Cefepime (3) Cefoxitin (4) Ertapenem (5) Ceftazidime <a href="#medicine/antibiotics">#medicine/antibiotics</a>  <br />
    A. (1)+(2)+(4)  <br />
    B. (1)+(4)+(5)  <br />
    C. (2)+(4)+(5)  <br />
    D. (1)+(4)  <br />
<mark>E. (2)+(5)</mark>  </p>
</li>
<li>
<p>以下哪些抗藥性細菌感染可被配對抗生素所治療? (1) Extended spectrum beta-lactamase (ESBL)-producing E. coli: Ertapenem (2) KPC carbapenemase-producing K. pneumoniae: Meropenem (3) VRE: Linezolid (4) MRSA: Daptomycin (5). Carbapenem-resistant Pseudomonas aeruginosa: Tigecycline <a href="#medicine/antibiotics">#medicine/antibiotics</a>  <br />
    A. (1)+(2)+(3)  <br />
<mark>B. (1)+(3)+(4)</mark>  <br />
    C. (3)+(4)+(5)  <br />
    D. (1)+(3)+(4)+(5)  <br />
    E. (1)+(3)  </p>
</li>
<li>
<p>Klebsiella pneumoniae 漸漸成為最重要的腸原性致病菌, 以下敘述何者正確? <a href="#medicine/antibiotics">#medicine/antibiotics</a>  <br />
    (1) 所有的臨床 Klebsiella pneumoniae菌株皆對 Ampicillin和 Ticarcillin具抗藥性  <br />
    (2) Extended spectrum beta-lactamase (ESBL)-producing K. pneumoniae對ceftriaxone和 ceftazidime具有抗藥性，但對 Ertapenem和 Fluoroquinolones 則皆具有感受性 (3) 可產生NDM-1 carbapenemase 的 K. pneumoniae 菌可用Tigecycline和Polymycins治療  <br />
    (4) 台灣可產生KPC carbapenemase 的 K. pneumoniae 菌株是透過質體產生抗藥性，並透過醫療照護機構傳播  <br />
    (5) 在台灣造成肝膿瘍或眼內炎主要是 ESBL-producing K. pneumoniae  <br />
    A. (1)+(2)+(3)  <br />
    B. (1)+(2)+(4)  <br />
<mark>C. (1)+(3)+(4)</mark>  <br />
    D. (1)+(3)+(5)  <br />
    E. (1)+(2)+(3)+(4)  </p>
</li>
<li>
<p>一位58歲男性因為髖骨骨折接受手術，手術後發生MRSA感染，於住院後接受清創手術及vancomycin注射，治療三週進步後出院。出院時使用口服linezolid治療，請問在門診追蹤下列哪一項較不重要？ <a href="#medicine/antibiotics">#medicine/antibiotics</a>  <br />
    A. Linezolid不可與單胺氧化酶抑制劑(monoamine oxidase inhibitor)或selective serotonin re-uptake inhibitor共同使用  <br />
    B. 要注意是否有乳酸中毒現象  <br />
<mark>C. 會造成QTc prolongation</mark>  <br />
    D. 使用超過2週有骨髓抑制風險  <br />
    E. 使用超過4週有視神經和周邊神經病變之風險。  </p>
</li>
<li>
<p>考量抗生素的特性及抗藥性問題, 在台灣目前經驗性抗生素在下列哪些情況不建議以 fluoroquinolone 當作第一線治療?(1)急性化膿性扁桃炎(2)急性膀胱炎(3)足癬合併下肢蜂窩組織炎(4)急性腦膜炎(5)急性腹瀉 <a href="#medicine/antibiotics">#medicine/antibiotics</a>  <br />
    A. (1)+(4)+(5)  <br />
    B. (1)+(2)+(5)  <br />
    C. (2)+(3)+(5)  <br />
<mark>D. (1)+(2)+(3)+(4)+(5)</mark>  <br />
    E. (1)+(2)+(3)+(4)  </p>
</li>
<li>
<p>下列有關於抗生素與其他藥物產生之交互作用配對，何者最不適當？ <a href="#medicine/antibiotics">#medicine/antibiotics</a>  <br />
    A. Metronidazole併用Ethanol發生disulfiram-like reaction  <br />
    B. Macrolides併用Fluoroquinolones會增加心律不整(arrhythmias)的風險  <br />
    C. Tetracyclines併用Warfarin會加強Warfarin抗凝血功能增加出血的風險  <br />
<mark>D. Rifampin會加強荷爾蒙作用，口服避孕藥(oral contraceptive)應減量使用</mark>  <br />
    E. Linezolid會增加adrenergic升壓藥的作用，發生不易控制的高血壓  </p>
</li>
<li>
<p>下列有關抗生素的主要抑制機轉配對，何者最不適當？ <a href="#medicine/antibiotics">#medicine/antibiotics</a>  <br />
    A. Cephalosporin–抑制細胞壁（Cell wall）合成  <br />
    B. Clindamycin– 抑制蛋白質（Protein synthesis）合成  <br />
<mark>C. Macrolide– 抑制DNA合成</mark>  <br />
    D. Sulfonamide– 抑制葉酸（Folate）合成  <br />
    E. Rifampin - 抑制RNA合成  </p>
</li>
<li>
<p>在台灣血糖控制不良的患者中，Klebsiella pneumoniae是重要且常見的腸源性致病菌，經常造成肝膿瘍、泌尿道感染等疾病，以下相關敘述，何者正確？ <a href="#medicine/antibiotics">#medicine/antibiotics</a>  <br />
    A. 臨床上wild type K. pneumoniae 可用Ampicillin治療  <br />
    B. 若檢驗結果為Extended spectrum beta-lactamase (ESBL) -producing K. pneumoniae 因對第一線抗生素有抗藥性，建議使用Ceftriaxone治療  <br />
<mark>C. 臨床上對於ESBL-producing K. pneumoniae 感染建議使用imipenem或ertapenem治療</mark>  <br />
    D. 可產生NDM-1 carbapenemase的K. pneumoniae可用Tigecycline和Trimethoprim /Sulfamethoxazole(TPM-SMX)治療  <br />
    E. 在台灣造成肝膿瘍或眼內炎的致病菌相對抗藥性較高，大多是屬於ESBL-producing K.  <br />
    pneumoniae  </p>
</li>
<li>
<p>有關抗生素治療與敗血症致病原的配對,下列哪些組合是正確的? <a href="#medicine/antibiotics">#medicine/antibiotics</a>  <br />
    (1) Ceftriaxone - Neisseria meningitidis  <br />
    (2) Penicillin - Group A Streptococcus  <br />
    (3) Clindamycin - Rickettsia  <br />
    (4) Ceftazidime- Enterococcus  <br />
<mark>A. (1)+(2)</mark>  <br />
    B. (2)+(3)  <br />
    C. (1)+(3)  <br />
    D. (2)+(4)  <br />
    E. (1)+(4)  </p>
</li>
<li>
<p>近年來抗藥性細菌的問題引起各國政府重視，尤其以ESKAPE這些菌最為棘手。下列敘述，何項組合最正確? <a href="#medicine/antibiotics">#medicine/antibiotics</a>  <br />
    (1) MRSA多以院內感染為主，社區型感染不需考慮MRSA。  <br />
    (2) Linezolid為抑菌型抗生素，所以不適合用於治療VRE (vancomycin-resistant Enterococcus)引起之菌血症。  <br />
    (3)由於抗藥性細菌盛行率節節高升，即便社區型感染還是得使用後線抗生素治療，以免治療失敗。  <br />
    (4)畜牧業使用抗生素，與人類得到抗藥性細菌感染有關係。  <br />
    (5)在台灣carbapenem-resistant Klebsiella pneumoniae (CRKP)主要與碳青黴烯類酶OXA-48有相關。  <br />
    A. (1)+(3)  <br />
    B. (1)+(2)+(3) +(4)  <br />
    C. (2)+(4)  <br />
    D. (2)+(4)+(5)  <br />
<mark>E. (4)+(5)</mark>  </p>
</li>
<li>
<p>有關penicillin過敏，以下敘述何者錯誤？ <a href="#medicine/antibiotics">#medicine/antibiotics</a>  <br />
    A. 越來越多研究認為多數註記為penicillin過敏反應的病人並沒有真正過敏，而且penicillin過敏反應會隨著時間過去而降低其產生過敏反應的機會，因此病史詢問、重新評估和正確註記很重要  <br />
    B. 曾被註記為penicillin過敏的病人因治療會接受更多vancomycin、fluoroquinolone或clindamycin等抗生素，而增加多重抗藥菌感染率及手術傷口感染的機會  <br />
    C. 大多數對penicillin過敏的病人並非對完整藥物分子過敏，而是對體內penicillin降解物與白蛋白共價連接產物過敏，以藥物溶液進行皮膚測試不足以識別大多數病人的過敏  <br />
    D. 目前國內臨床病人處置以病史為主，若無penicillin過敏病史，於符合適應症時可以直接使用penicillin，並不須以藥物溶液進行皮膚測試;惟完備急救設備藥物和人員環境是所有醫療院所之基本法規要求  <br />
<mark>E. 若病史有中度或高度penicillin過敏反應風險者，建議以藥物溶液逕行進行皮膚測試</mark>  </p>
</li>
</ol>







  
    
  
  


  <aside class="md-source-file">
    
      
  <span class="md-source-file__fact">
    <span class="md-icon" title="Last update">
      <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M21 13.1c-.1 0-.3.1-.4.2l-1 1 2.1 2.1 1-1c.2-.2.2-.6 0-.8l-1.3-1.3c-.1-.1-.2-.2-.4-.2m-1.9 1.8-6.1 6V23h2.1l6.1-6.1-2.1-2M12.5 7v5.2l4 2.4-1 1L11 13V7h1.5M11 21.9c-5.1-.5-9-4.8-9-9.9C2 6.5 6.5 2 12 2c5.3 0 9.6 4.1 10 9.3-.3-.1-.6-.2-1-.2s-.7.1-1 .2C19.6 7.2 16.2 4 12 4c-4.4 0-8 3.6-8 8 0 4.1 3.1 7.5 7.1 7.9l-.1.2v1.8Z"/></svg>
    </span>
    <span class="git-revision-date-localized-plugin git-revision-date-localized-plugin-timeago" title="December 29, 2025 03:37:30 UTC"><span class="timeago" datetime="2025-12-29T03:37:30+00:00" locale="en"></span></span><span class="git-revision-date-localized-plugin git-revision-date-localized-plugin-iso_date" title="December 29, 2025 03:37:30 UTC">2025-12-29</span>
  </span>

    
    
    
    
  </aside>



  



      
    </article>
  </div>

          
<script>var target=document.getElementById(location.hash.slice(1));target&&target.name&&(target.checked=target.name.startsWith("__tabbed_"))</script>
        </div>
        
          <button type="button" class="md-top md-icon" data-md-component="top" hidden>
  
  <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M13 20h-2V8l-5.5 5.5-1.42-1.42L12 4.16l7.92 7.92-1.42 1.42L13 8v12Z"/></svg>
  Back to top
</button>
        
      </main>
      
        <footer class="md-footer">
  
  <div class="md-footer-meta md-typeset">
    <div class="md-footer-meta__inner md-grid">
      <div class="md-copyright">
  
  
    Made with
    <a href="https://squidfunk.github.io/mkdocs-material/" target="_blank" rel="noopener">
      Material for MkDocs
    </a>
  
</div>
      
        <div class="md-social">
  
    
    
    
    
    <a href="mailto:<notes.awkward473@passinbox.com>" target="_blank" rel="noopener" title="send me an email" class="md-social__link">
      <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><!--! Font Awesome Free 6.6.0 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2024 Fonticons, Inc.--><path d="M64 112c-8.8 0-16 7.2-16 16v22.1l172.5 141.6c20.7 17 50.4 17 71.1 0L464 150.1V128c0-8.8-7.2-16-16-16H64zM48 212.2V384c0 8.8 7.2 16 16 16h384c8.8 0 16-7.2 16-16V212.2L322 328.8c-38.4 31.5-93.7 31.5-132 0L48 212.2zM0 128c0-35.3 28.7-64 64-64h384c35.3 0 64 28.7 64 64v256c0 35.3-28.7 64-64 64H64c-35.3 0-64-28.7-64-64V128z"/></svg>
    </a>
  
</div>
      
    </div>
  </div>
</footer>
      
    </div>
    <div class="md-dialog" data-md-component="dialog">
      <div class="md-dialog__inner md-typeset"></div>
    </div>
    
    
    <script id="__config" type="application/json">{"base": "../..", "features": ["navigation.tabs", "navigation.tabs.sticky", "navigation.sections", "navigation.tracking", "navigation.top", "navigation.indexes", "toc.follow", "search.highlight"], "search": "../../assets/javascripts/workers/search.b8dbb3d2.min.js", "translations": {"clipboard.copied": "Copied to clipboard", "clipboard.copy": "Copy to clipboard", "search.result.more.one": "1 more on this page", "search.result.more.other": "# more on this page", "search.result.none": "No matching documents", "search.result.one": "1 matching document", "search.result.other": "# matching documents", "search.result.placeholder": "Type to start searching", "search.result.term.missing": "Missing", "select.version": "Select version"}}</script>
    
    
      <script src="../../assets/javascripts/bundle.af256bd8.min.js"></script>
      
        <script src="../../js/timeago.min.js"></script>
      
        <script src="../../js/timeago_mkdocs_material.js"></script>
      
        <script src="../../javascripts/mathjax.js"></script>
      
        <script src="https://polyfill.io/v3/polyfill.min.js?features=es6"></script>
      
        <script src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-mml-chtml.js"></script>
      
        <script src="https://cdn.jsdelivr.net/gh/ObsidianPublisher/assets@main/dist/javascript.js"></script>
      
    
  </body>
</html>